Search Results
Viewing: 491-500 of 3201 | All
Article
October 2010
Dr. Annemieke Aartsma-Rus discusses progress in antisense oligonucleotide therapies.
News
Saliva, Genomic Analysis Used to Identify Promising Biomarkers for Persistent Post-Concussive Symptoms in Children
In a study published in Frontiers in Public Health, researchers with the Center for Injury Research and Policy, Division of Sports Medicine, and the Steve and Cindy Rasmussen Institute for Genomic Medicine at Nationwide Children’s Hospital have demonstrated a method by which increased risk of persistent post-concussive symptoms (PPCS) in children with concussion can be identified. This could allow families and their care teams to better assess recovery time of children with concussion.
Article
Timothy Cripe Lab
Under the direction of Timothy Cripe, MD, PhD, the Cripe Lab focuses on developing and testing new, targeted therapies for pediatric solid tumors and translating those findings into clinical studies.
News
NFL Charities Awards More Than $1.6 Million in Sports Medical Research Grants
NFL Charities, the charitable foundation of the National Football League owners, has awarded more than $1.6 million in grants to support sports-related medical research at 16 organizations, the NFL announced today. Of these grants, $988,224 will go to studying concussion prevention and treatment.
Article
OpenClinica Training Manual
Article
MCM-RAG Members
The Molecular and Cellular Medicine-Research Affinity Group is made up of a steering committee and members from both Nationwide Children's Hospital and The Ohio State University. Learn more about its members.